Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $2.24 | Change: $-0.20 | %Change: -8.20%
Volume: 150,654 | Day High/Low: 2.68/2.20 | 52 Week High/Low: 3.13/0.405
View modes: 
0 stars

INTERESTING ARTICLE RE I.P. KNOWLEDGE-- ANTI-COMPETE

For Thor interest, a rather interesting article re R/D employees who split from the mother ship. Reminds me somewhat of the ZEN3365 fiasco:      Bristol-Myers Squibb ($BMY) is the leader right now in...read more
1 star

RE:RE:RE:RE:RE:RE:RVX ON THE MOVE?

Evidently my earlier comments on the shorts upset them and they stuck it back to me...LOL!  rate and reply
0 stars

WELL....

That was a very odd trading day! I suspect someone wanted their $$ out in a big hurry. Silly rabbit.  rate and reply
0 stars

RE:RE:RE:RE:RE:RVX ON THE MOVE?

ron...back where we started from this morning....Ouch one more time. :) G1945V  rate and reply
1 star

insiders all loaded up? canadianinsider report

lots of activity last week 0 options and RSU's https://canadianinsider.com/company?menu_tickersearch=rvx May 26/15 May 21/15 Johansson, Dr. Jan Ove Direct Ownership Restricted Share Units (RSU's...read more
5 stars

RE:RVX NEW NR

Thanks Jkj. What can I say. The positive news about Resverlogix and rvx-208 just keeps coming. They were pioneers in epigenetics and continue to discover new indications for rvx-208. I often think...read more
1 star

RE:RE:RE:RE:RVX ON THE MOVE?

Ouch!  rate and reply
1 star

RE:RE:RE:RVX ON THE MOVE?

Last month's shorters are now "getting kicked in the face" 😆😋  rate and reply
1 star

RE:RE:RVX ON THE MOVE?

Now up $.16 :)  rate and reply
0 stars

RE:RVX ON THE MOVE?

FYI: Up 8 cents to $201 in the states on low volume.😳 jk  rate and reply
5 stars

RVX NEW NR

News Release Issued: Jun 1, 2015 (5:30am MDT) Resverlogix Presents New Data at 52nd Annual European Renal Association - European Dialysis & Transplant Association Congress (ERA-EDTA) RVX-208, the...read more
1 star

RVX ON THE MOVE?

Maybe we'll start to fly again in June.....:)  rate and reply
5 stars

RVX in the news

http://www.prnewswire.com/news-releases/resverlogix-presents-new-data-at-52nd-annual-european-renal-association---european-dialysis--transplant-association-congress-era-edta-505659241.html  rate and reply
1 star

RE:Check Out PubMed, keywords zenith epigenetics, May 15 pub

topcoin..The lender Ken Dent ( Eastern Capital) has beneficial ownership and control over 25,248,640 common shares of Zenith, which represents approximately 25.1%. He is not worried.   jmo G1945V  rate and reply
0 stars

RE:Check Out PubMed, keywords zenith epigenetics, May 15 pub

Top, can you give us a copy of the abstract or a link or citation. I could not find anything on the 15, related toZenith, but I have very poor near vision.Thanks, jk  rate and reply
0 stars

CHECK OUT PUB MED MAY 11th FOR PAPER AUTHORED BY MCLURE

WAGNER, AND OTHERS, RE PURCHANG BR4 AGENTS. MAYBE THIS IS WHERE ZN3365 WENT? http://www.ncbi.nlm.nih.gov/pubmed/26022843  rate and reply
0 stars

RE:RE:RE:In talking with Sarh this morning

I also talked to Sarah a few weeks back and she told me the same thing they expect to have trial running by end of H2.  Also Sarah adviced that she has not heard any issues in regards to closing...read more
0 stars

Check Out PubMed, keywords zenith epigenetics, May 15 pub

In addition Zenith spin out moved all Zenith IP out from under the debt burden at RVX I was very surprised lender allowed it to escape Think that was the plan or good part of it  rate and reply
2 stars

When will we see $2.80 again?

If the trend holds, we may see $2.80 by end of second week in June. (based on past performance) jmo G1945V  04/16/15 2.68 2.68 2.02 2.11 508,950...read more
0 stars

WONDER IF RVX-208 AFFECTS BMP IN T2DM

FYI: Cardiovascular Diabetology 2015, 14:64  doi:10.1186/s12933-015-0214-3 Published: 24 May 2015 Abstract (provisional) Background Although Bone morphogenetic protein-2 (BMP...read more